Trial Search Results

Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication

Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsible for mediating its pain-relieving properties are not known. We will use functional magnetic resonance imaging (FMRI) to investigate the neural and functional correlates of pain.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: duloxetine
  • Drug: Placebo

Phase:

N/A

Eligibility


Inclusion Criteria:- Males aged 18-60

   - Back Pain

   - Must be able to comply with study visit schedule and other study requirements

   - Capable of performing the experimental tasks

Exclusion Criteria:- Contraindications for MRI examination (e.g., metallic implants such as
pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body)

   - Known hypersensitivity to duloxetine or any of the inactive ingredients

   - Uncontrolled narrow-angle glaucoma

Ages Eligible for Study

18 Years - 60 Years

Genders Eligible for Study

Male

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Neil Chatterjee
6507240522
Not Recruiting